Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease (NCT01099982)
Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease, Effects of Mechanical Unloading on Myocardial Function and Structure in Humans
🩺 Plain-English Summary (8th-Grade Level)
Hypothesis: Tissue and serum samples collected from end-stage heart failure patients receiving left ventricular assist device implantation (LVAD) or heart transplantation will provide information regarding the basic science of heart disease. Tissue and serum samples collected from a limited numbers of "healthy controls" (donor grafts that were not utilized for heart transplantation) will serve as a comparator in research database projects. Design: This is a registry project; there are no investigational treatments, drug or procedures associated with participation in registry activities. This project is an organized functional data and tissue data gathering and storing (database) endeavor with specific focus on the functional, structural, and molecular aspects of heart failure. Data collection will not immediately influence the course of treatment for any patient.
Who can join: Review the eligibility criteria below.
Location: Intermountain Medical Center — Murray, Utah
Age range: 13 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Intermountain Medical Center — Murray, Utah
- University of Utah Health Sciences Center — Salt Lake City, Utah
- VA Salt Lake City Health Care System — Salt Lake City, Utah
📞 Contact the Study Coordinator
Phone: (801) 585-2944
Email: john.kirk@hsc.utah.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Congestive Heart Failure
- SyncAV Post-Market Trial — Huntsville, Alabama
- Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study — Boston, Massachusetts
- Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure — Birmingham, Alabama
- Boston Medical Center Ultrasound Decongestion Study in Heart Failure — Boston, Massachusetts
- Palliative Care for People With HF — Indianapolis, Indiana
Explore by condition: All Congestive Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.